Lipopolysaccharide activates nuclear factor kB in rat intestine: Role of endogenous platelet-activating factor and tumour necrosis factor

British Journal of Pharmacology

Volumn 129, Issue 2, 2000, Pages 307-314

  De Plaen, Isabelle G ^a   Tan, Xiao Di ^a   Chang, Hong ^a   Wang, Liya ^a   Remick, Daniel G ^b   Hsueh, Wei ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

In vivo; Inflammation; Lipopolysaccharide; Transcription factors

Indexed keywords

ANTISERUM; BACTERIUM LIPOPOLYSACCHARIDE; BEPAFANT; CYTOKINE ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN SUBUNIT; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ILEUM; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE; INTESTINE EPITHELIUM; LAMINA PROPRIA; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; RAT;

EID: 0033979832     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703055     Document Type: Article

References (46)

1. Baeuerle, P.A. & Henkel T. (1994). Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol., 12, 141-179.
2. Barnes, P.J. & Karin, M. (1997). Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. New. Engl. J. Med., 336, 1066-1071.
3. Beg, A.A. & Baldwin, Jr. A.S., (1994). Activation of multiple NF-kappa B, Rel DNA-hinding complexes by tumour necrosis factor. Oncogene, 9, 1487-1492.
4. Benveniste, J. (1988). PAF-acether, an ether phospholipid with biological activity. Prog. Clin. Biol. Res., 282, 73-85.
5. Blackwell, T.S., Blackwell, T.R., Holden, E.P., Christman, B.W. & Christman, J.W. (1996). In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J. Immunol., 157, 1630-1637.
6. Bohrer, H., Qiu. F., Zimmermann, T., Zhang, Y., Jllmer, T, Mannel, D., Bottiger, B.W., Stern, D.M., Waldherr, R., Saeger, H.D., Ziegler, R., Bierhaus, A., Martin, E. & Nawroth, P.P. (1997). Role of NFkappaB in the mortality of sepsis. J. Clin. Invest., 100, 972-985.
7. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochcm., 72, 248-254.
8. Cordle, S., Donald, R., Read, M.A. & Hawiger, J. (1993). Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NFκB proteins in human monocytic THP-1 cells. J. Biol. Chem., 268, 11803-11810.
9. Couturier, C., Jahns, G., Kazatchkine, M.D. & Haeffner-Cavaillon, N. (1992). Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaccharide-stimulated human monocytes. Eur. J. Immunol., 22, 1461-1466.
10. De Plaen, I.G., Tan, X.D., Chang, H., QU, X.-W., Liu, Q. & Hsueh, W. (1998). Intestinal NF-κB is activated, mainly as p50 homodimers, by platelet-activating factor. Biochim. Biophys. Acta., 1392, 185-192.
11. Deryckere, F. & Gannon, F. (1994). A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques, 16, 405.
12. De Wit, H., Hoogstraten, D., Halie, R.M. & Vellenga, E. (1996). Interferon-γ modulates the lipopolysaccharide-induced expression of AP-1 and NF-κB at the mRNA and protein level in human monocytes. Exp. Hematol., 24, 228-235.
13. Ding, A., Hwang, S., Lander, H.M. & Xie, Q.-W. (1995). Macrophages derived from C3H/HeJ (Lpsd) mice respond to bacterial lipopolysaccharide by activating NF-κB. J. Leukocyte Biol., 57, 174-179.
14. Essani, N.A., McGuire, G.M., Manning, A.M. & Jaeschke, H. (1996). Endotoxin-induced activation of the nuclear transcription factor kappa B and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J. Immunol., 156, 2956-2963.
15. Geng, Y., Zhang, B. & Lotz, M. (1993). Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J. Immunol., 151, 6692 6700.
16. Gonzalez-Crussi, F. & Hsueh, W. (1983). Experimental model of ischemic bowel necrosis: The role of platelet-activating factor and endotoxin. Am. J. Pathol., 112, 127-135.
17. Handley, D.A. (1990). Platelet-activating factor as a mediator of endotoxin-related diseases. In Handley, D.A., Saunders, R.N., Houlihan, W.J. & Tomasch J.C. eds. Platelet-activating factor in Endotoxin and Immune Diseases, pp. 451-496. New York: Marcel Dekker.
18. Henninger, D.D., Panes, J., Eppihimer, M., Russell, J., Gerritsen, M., Anderson, D.C. & Granger, D.N. (1997). Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J. Immunol., 158, 1825-1832.
19. Heumann, D., Gallay, P., Barras, C., Zaech, P., Ulevitch, R.J., Tobias, P.S., Glauser, M.P. & Baumgartner, J.D. (1992). Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immuno!., 148, 3505-3512.
20. Hsueh, W., Caplan, M.S., Tan, X., MacKendrick, W. & Gonzalez-Crussi, F. (1998). Necrotizing enterocolitis of the newborn: Pathogenetic concepts in perspective. Ped. Dev. Pathol., 1, 2-16.
21. Hsueh, W., Gonzalez-Crussi, F. & Arroyave J. (1987). Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J., 1, 403-405.
22. Huang, L., Tan, X., Crawford, S.E. & Hsueh, W. (1994). Platelet-activating factor and endotoxin induce tumour necrosis factor gene expression in rat intestine and liver. Immunology, 83, 65-69.
23. Jung, H.C., Eckmann, L., Yang, S.K., Panja, A., Fierer, J., Morzycka-Wroblewska, E. & Kagnoff, M.F. (1995). A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest., 95, 55-65.
24. Kopp, E.B. & Ghosh S. (1995). NF-kappa B and rel proteins in innate immunity. Adv. Immunol., 58, 1-27.
25. Kubes, P., Ibbotson, G., Russell, J., WALLACE, J.L. & Granger, D.N. (1990). Role of platelet-activating factor in ischemia/ reperfusion-induced leukocyte adherence. Am. J. Physiol., 259, 300-305.
26. Libermann, T.A. & Baltimore, D. (1990). Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol., 10, 2327-2334.
27. McGee, D.W., Bamberg, T., Vitkus, S.J. & McGhee, J.R. (1995). A synergistic relationship between TNF-alpha, IL-1 beta, and TGF-beta 1 on IL-6 secretion by the IEC-6 intestinal epithelial cell line. Immunology, 86, 6-11.
28. Miyamoto, S. & Verma, I.M. (1995). Rel/NFkappa B, I kappa B story. Adv. Cancer Res., 66, 255-292.
29. Neurath, M.F., Pettersson, S., Meyer, K.-H, Buschenfelde, Z & Strober, W. (1996). Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nature Medicine, 2, 998-1004.
30. Podolsky, D.K. (1997). Lessons from genetic model of inflammation bowel disease. Acta Gastrol. Belg., 60, 163-165.
31. Ray, A. & Ray, B.K. (1995). Lipopolysaccharide-mediated induction of the bovine interleukin-6 gene in monocytes requires both NF-kappa B and C/EBP binding sites. DNA Cell biol., 14, 795-802.
32. Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel R., Baeuerle, P.A., Scholmerich, J. & Gross, V. (1998). Nuclear Factor-κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology, 115, 357-369.
33. Sanceau, J., Kaisho, T., Hirano, T. & Wietzerbin, J. (1995). Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. J. Biol. Chem., 270, 27920-27931.
34. Savkovic, S., Loutsouris, A. & Hecht, G. (1997). Activation of NF-κB in intestinal epithelial cells by enteropathogenic Escherichia Coli. Am. J. Physiol., 273, 1160-1167.
35. Schutze, S., Wiegmann, K., Machleidt, T. & Kronke, M. (1995). TNF-induced activation of NF-κB. Immunobiol., 193, 193-203.
36. Shakhov, A.N., Collart, M.A., Vassalli, P., Nedospasov, S.A. & Jongeneel, C.V. (1990). Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J. Exp. Med., 171, 35-47.
37. Smith Jr. M.F., Eidlen, D., Arend, W.D. & Gutierrez-Hartmann, A. (1994). LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. J. Immunol., 153, 3584-3593.
38. Sun, S.-C., Ganchi, P.A., Ballard, D.W. & Greene, W.C. (1993). NF-κB controls expression of inhibitor IκB-alpha: Evidence for an inducible autoregulatory pathway. Science, 259, 1912-1915.
39. Sun, X., MacKendrick, W., Tien, J., Huang, W., Caplan, M. & Hsueh, W. (1995). Endogenous bacterial toxins are required for the injurious action of platelet-activating factor in rats. Gastroenterology, 109, 83-88.
40. Sun, X.M., QU. X.-W., Huang, W., Granger, D.N., Bree, M. & Hsueh, W. (1996). The role of leukocyte beta 2-integrin in PAF-induced shock and intestinal injury. Am. J. Physiol., 270, 184-190.
41. Tan, X., Sun, X., Gonzalez-Crussi, F.X., Gonzalez-Crussi, F. & Hsueh, W. (1994). PAF and TNF increase the precursor of NF-kappa B p50 mRNA in mouse intestine: quantitative analysis by competitive PCR. Biochim. Biophys. Acta., 1215, 157-162.
42. 2 in the rat intestine. Role of polymorphonuclear leukocytes. J. Immunol., 156, 2985-2990.
43. Toth, P.D. (1990). The biological effects of PAF antagonists on endotoxemia. In: Handley, D.A., Saunders, R.N., Houlihan, W.J. & Tomesch, J.C. eds. Platelet-activating Factor in Endotoxin and Immune Diseases, pp. 589-608. New York: Marcel Dekker.
44. Tracey, K.J., Beutler, B., Lowry, S F., Merrywaether, J., Wolpe, S., Milsark, I.W., Hariri, R.J., Fahey, T.J.3D, Zenella, A., Albert, J.D., Shires, G.T. & Cerami, A. (1986). Shock and tissue injury induced by recombinant human cachectin. Science, 234, 470-474.
45. Tracey, K.J., Fong, Y., Hesse, D.G., Manogue, K.R., Lee, A.T., Juo, G.C., Lowry, S.F. & Cerami, A. (1987). Anti-cachectin/ TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature, 330, 662-664.
46. Ziegler-Heitbrock, H.W., Wedel, A., Schraut, W., Strobel, M., Wendelgass, P., Sternsdorf, T., Baeuerle, P.A., Haas, J.G. & Riethmuller, G. (1994). Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J. Biol. Chem., 269, 17001-17004.